NCT06645964View on ClinicalTrials.gov

Evaluation of The Performance of Retinow AI Software

CompletedOBSERVATIONAL
Enrollment

915

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

October 1, 2023

Study Completion Date

October 1, 2023

Conditions
Diabetic RetinopathyGlaucomaMacular Degeneration
Trial Locations (1)

Unknown

Ankara Bilkent Şehir Hastanesi, Ankara

All Listed Sponsors
lead

Retinow Health Technologies and R&D Industry Joint Stock Company

OTHER

NCT06645964 - Evaluation of The Performance of Retinow AI Software | Biotech Hunter | Biotech Hunter